The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.
about
Barriers to inhaled gene therapy of obstructive lung diseases: A reviewEvaluation of New Fluorescent Lipophosphoramidates for Gene Transfer and Biodistribution Studies after Systemic AdministrationLung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier.Expert opinion in biological therapy: update on developments in lung gene transfer.Synthetic vectors for gene delivery: An overview of their evolution depending on routes of administration.Assessment of selected media supplements to improve F/HN lentiviral vector production yields.Inhaled gene delivery: a formulation and delivery approach.Combination delivery of antigens and CpG by lanthanides-based core-shell nanoparticles for enhanced immune response and dual-mode imaging.Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.Non-viral gene therapy that targets motor neurons in vivo.Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties.Rapid identification of novel functional promoters for gene therapy.Could recent advances in DNA-loaded nanoparticles lead to effective inhaled gene therapies?Clinically Usable Interleukin 12 Plasmid without an Antibiotic Resistance Gene: Functionality and Toxicity Study in Murine Melanoma Model.
P2860
Q29248141-00FFDF04-B934-442E-BCCA-37950DDCD4E7Q36324477-4DC62B61-3F41-49D5-9F4B-9D3F9BD66862Q37633436-48B66F13-C232-47D0-960C-8D43DD8792EDQ38071683-75292350-3C68-46B2-A929-CBC1E09A489DQ38513773-2B79D94E-13AE-4E34-A6B7-87D5E8CD0AE5Q38693642-38A3FD8C-71F0-4E11-9CC2-08B09E8B9CB5Q38900131-6EC3D13E-B6F6-434F-BAF4-7E9D00C755EBQ39176137-844A5399-DF29-466D-926B-CEB1F4B63C73Q39556636-A1D12348-69BF-4D76-BC34-215296982472Q41760723-AAE06107-3907-4563-84F2-50167A0482CEQ44832157-4C9BDD99-0305-4B27-BD19-7F5DA738DFE5Q45880287-F849A239-702F-49F5-BAFB-DBBF274F05A7Q45882390-92D2E938-832C-4B07-BF73-2A9556F504FCQ53705456-F9E33E2A-CA40-40CB-ABAC-AB6454A7A836
P2860
The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The use of CpG-free plasmids t ...... elivery of pDNA/PEI complexes.
@en
The use of CpG-free plasmids t ...... elivery of pDNA/PEI complexes.
@nl
type
label
The use of CpG-free plasmids t ...... elivery of pDNA/PEI complexes.
@en
The use of CpG-free plasmids t ...... elivery of pDNA/PEI complexes.
@nl
prefLabel
The use of CpG-free plasmids t ...... elivery of pDNA/PEI complexes.
@en
The use of CpG-free plasmids t ...... elivery of pDNA/PEI complexes.
@nl
P2093
P50
P1433
P1476
The use of CpG-free plasmids t ...... delivery of pDNA/PEI complexes
@en
P2093
Anna E Lawton
Dominique McCormick
Graciela Nunez-Alonso
Ian A Pringle
Lee A Davies
Rebekka Harding-Smith
Reto P Bazzani
Stephanie G Sumner-Jones
Thomas C Roberts
P304
P356
10.1016/J.BIOMATERIALS.2012.04.019
P577
2012-05-08T00:00:00Z